Stock to Observe: Stoke Therapeutics, Inc. (NASDAQ: STOK)
Stoke Therapeutics, Inc. (NASDAQ: STOK) changed -0.59% to recent value of $23.55. The stock transacted 88230 shares during most recent day however it has an average volume of 138.31K shares. It spotted trading -39.68% off 52-week high price. On the other end, the stock has been noted 22.59% away from the low price over the last 52-weeks.
Stoke Therapeutics, Inc., (STOK) recently stated financial results for the third quarter of 2019.
Third Quarter and Year to Date 2019 Results
Net loss for the third quarter of 2019 was $8.6M, contrast to net loss of $3.3M for the same period in 2018. Net loss for the nine months ended September 30, 2019 was $22.2M, contrast to net loss of $8.2M for the same period in 2018.
Research and development expenses for the third quarter of 2019 was $6.5M, contrast to $2.2M for the same period in 2018. Research and development expense for the nine months ended September 30, 2019 was $16.7M, contrast to $5.4M for the same period in 2018.
General and administrative expenses for the three months ended September 30, 2019 were $3.3M, contrast to $1.1M for the same period in 2018. General and administrative expenses for the nine months ended September 30, 2019 were $7.9M, contrast to $2.9M for the same period in 2018.
The increases in expenses for the 2019 periods over the same periods in 2018 primarily relate to increases in costs associated with personnel costs, third party contracts, consulting, facilities and other costs associated with development activities for STK-001, research on additional therapeutics and growing a public corporation.
As of September 30, 2019, Stoke had about $233.2M in cash, cash equivalents and restricted cash, which is anticipated to fund operations into 2023.
According to the most recent quarter its current ratio was 48.1 that represents company’s ability to meet its current financial obligations. The price moved ahead of -9.81% from the mean of 20 days, -8.89% from mean of 50 days SMA and performed -10.80% from mean of 200 days price. Company’s performance for the week was -7.03%, -12.03% for month and YTD performance remained -16.84%.
